Pacira BioSciences (PCRX) EBT Margin (2010 - 2026)
Pacira BioSciences' EBT Margin was 1.33% in Q2 2026, up 2.39 percentage points from -1.06% a year earlier but down 1.49 percentage points from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) EBT Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pacira BioSciences' EBT Margin was 2.37% through Jun 30, 2026, up 17.46 percentage points year-over-year; for FY2025, it was 2.32%, up 11.33 percentage points from FY2024.
- EBT Margin shows a five-year change of -2.35 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -9.00% in FY2024 (-18.14 pp), 9.14% in FY2023 (+7.15 pp), 1.99% in FY2022 (-8.42 pp) and 10.42% in FY2021 (+5.74 pp).
- Quarterly EBT Margin has moved between -82.37% (Q3 2024) and 22.34% (Q2 2023) over five years.
- Compared with a year earlier, EBT Margin was higher in two of the last eight quarters, with an average year-over-year change of -5.96 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q3 2025 (a gain of 87.68 percentage points); the worst was Q3 2024 (a drop of 92.50 percentage points).
- Per Business Quant data, PCRX's EBT Margin in the three quarters before Q2 2026 was 2.82% (Q1 2026), 0.29% (Q4 2025) and 5.31% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Pacira BioSciences | 1.46 Bn | 468.61 Mn | 139.42 Mn | 16.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.31% |
| Jun 30, 2026 | 1.33% |
| Mar 31, 2026 | 2.82% |
| Dec 31, 2025 | 0.29% |
| Sep 30, 2025 | 5.31% |
| Jun 30, 2025 | -1.06% |
| Mar 31, 2025 | 5.15% |
| Dec 31, 2024 | 13.63% |
| Sep 30, 2024 | -82.37% |
| Jun 30, 2024 | 20.55% |
| Mar 31, 2024 | 8.16% |
| Dec 31, 2023 | 18.60% |
| Sep 30, 2023 | 10.13% |
| Jun 30, 2023 | 22.34% |
| Mar 31, 2023 | -16.51% |
| Dec 31, 2022 | -10.51% |
| Sep 30, 2022 | 1.24% |
| Jun 30, 2022 | 12.99% |
| Mar 31, 2022 | 4.62% |
| Dec 31, 2021 | -3.89% |
API Access
Pacira BioSciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();